Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo

Published:2018-06-20 Issue:1 Volume:33 Page:88-98
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Schneidt Viktor,Ilecka Marta,Dreger Peter,van Zyl Dwain G.,Fink Susanne,Mautner Josef,Delecluse Henri-Jacques

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-018-0160-7.pdf

Reference47 articles.

1. Dreger P, Schetelig J, Andersen N, Corradini P, van Gelder M, Gribben J, et al. Managing high-risk CLL during transition to a new treatment era: stem cell transplantation or novel agents? Blood. 2014;124:3841–9.

2. Mato A, Porter DL. A drive through cellular therapy for CLL in 2015: allogeneic cell transplantation and CARs. Blood. 2015;126:478–85.

3. Yu X, Ilecka M, Bartlett EJ, Schneidt V, Bhat R, Mautner J, et al. Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+T cells. Blood. 2015;125:1601–10.

4. Lunde E, Bogen B, Sandlie I. Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells. Mol Immunol. 1997;34:1167–76.

5. Lunde E, Munthe LA, Vabo A, Sandlie I, Bogen B. Antibodies engineered with IgD specificity efficiently deliver integrated T cell epitopes for antigen presentation by B cells. Nat Biotechnol. 1999;17:670–5.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-epitope conjugates deliver immunogenic T-cell epitopes more efficiently when close to cell surfaces;mAbs;2024-03-18

2. Comparison of methods generating antibody-epitope conjugates for targeting cancer with virus-specific T cells;Frontiers in Immunology;2023-05-16

3. Sensitization of Tumors for Attack by Virus-Specific CD8+ T-Cells Through Antibody-Mediated Delivery of Immunogenic T-Cell Epitopes;Frontiers in Immunology;2019-08-21

4. Progress in EBV Vaccines;Frontiers in Oncology;2019-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3